BACKGROUND
Surgical approaches such as the subvastus (SV) and medial parapatellar (MPP) for total knee arthroplasty (TKA) approaches may influence postoperative recovery, pain, and functional outcomes. However, evidence comparing these approaches remains inconsistent. Our aim was to compare the clinical outcomes and sa...
M. Muneeb, Ayesha Ahmad, Izhar Ul Haq et al.· Journal of Arthroplasty· 0 citations
OBJECTIVE
To compare the safety, efficacy, and patient-centered outcomes of transradial access (TRA) versus transfemoral access (TFA) in patients undergoing diagnostic cerebral angiography.
METHODS
PubMed, Embase, and Scopus were searched from inception through April 2026. RCTs and observational studies comparing TRA...
A. A. Malik, Goodluck Oparaugo, Sajjad Khan et al.· Neurological Research· 0 citations
BackgroundTriple-negative breast cancer (TNBC) is an aggressive subtype with limited targeted treatment options. Platinum agents, particularly carboplatin's DNA damaging properties suggest efficacy, its impact on survival outcomes and toxicity remains uncertain.MethodsPubMed, Embase, Scopus, Cochrane Library, and Clini...
M. Amjad, M. Bashir, Khwaja Waleed Maqbool et al.· Journal of Oncology Pharmacy...· 0 citations
PURPOSE
To evaluate the efficacy and safety of oral PCSK9 inhibitors in adults with hypercholesterolemia by synthesizing evidence from randomised controlled trials.
METHODS
This systematic review and meta-analysis followed PRISMA guidelines and was registered on PROSPERO (CRD420261303350). PubMed, Embase and Scopus w...
M. H. Khattak, Sohana Memon, H. Bibi et al.· Diabetes, obesity and metabo...· 0 citations
OBJECTIVES
Sacituzumab govitecan (SG), a Trop-2-directed antibody-drug conjugate delivering SN-38, has shown promising activity in advanced breast cancer. However, variability across trials and inclusion of nonrandomized data in prior meta-analyses limit the certainty of its efficacy and safety. This study aimed to eva...
M. Amjad, M. Rafique, S. F. Hussain et al.· American Journal of Clinical...· 0 citations
Baxdrostat, particularly at 2 mg, provides clinically meaningful BP reductions, and serious safety outcomes remain entirely comparable to control, which highlights a reassuring safety profile.
B. Khan, Muhammad Yahya, H. Khan et al.· Naunyn-Schmiedeberg's Archiv...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.